Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.
Open Access
- 1 April 1995
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 95 (4) , 1528-1538
- https://doi.org/10.1172/jci117825
Abstract
Type III cGMP-inhibited phosphodiesterases (PDE3s) play important roles in hormonal regulation of lipolysis, platelet aggregation, myocardial contractility, and smooth muscle relaxation. We have recently characterized two PDE3 subtypes (PDE3A and PDE3B) as products of distinct but related genes. To elucidate their biological roles, in this study we compare cellular patterns of gene expression for these two enzymes during rat embryonic and postnatal development using in situ hybridization. PDE3B [corrected] mRNA is abundant in adipose tissue and is also expressed in hepatocytes throughout development. This mRNA is also highly abundant in embryonic neuroepithelium including the neural retina, but expression is greatly reduced in the mature nervous system. Finally, PDE3B [corrected] mRNA is localized in spermatocytes and renal collecting duct epithelium in adult rats. PDE3B mRNA is highly expressed in the cardiovascular system, including myocardium and arterial and venous smooth muscle, throughout development. It is also abundant in bronchial, genitourinary and gastrointestinal smooth muscle and epithelium, megakaryocytes, and oocytes. PDE3A [corrected] mRNA demonstrates a complex, developmentally regulated pattern of gene expression in the central nervous system. In summary, the two different PDE3s show distinctive tissue-specific patterns of gene expression suggesting that PDE3B [corrected] is involved in hormonal regulation of lipolysis and glycogenolysis, while regulation of myocardial and smooth muscle contractility appears to be a function of PDE3A [corrected]. In addition, the present findings suggest previously unsuspected roles for these enzymes in gametogenesis and neural development.Keywords
This publication has 43 references indexed in Scilit:
- The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterasesMolecular and Cellular Biochemistry, 1993
- Regulation and function of cyclic nucleotidesCurrent Opinion in Cell Biology, 1992
- Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscleBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cellsCellular Signalling, 1992
- Insulin and lipolytic hormones stimulate the same phosphodiesterase isoform in rat adipose tissueBiochemical and Biophysical Research Communications, 1989
- Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human plateletsBiochemical Pharmacology, 1988
- Purification of an insulin‐sensitive cyclic AMP phosphodiesterase from rat liverEuropean Journal of Biochemistry, 1988
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.Circulation, 1986
- Purification and characterization of a human platelet cyclic nucleotide phosphodiesteraseBiochemistry, 1984